|Bid||0.0876 x 0|
|Ask||0.1016 x 0|
|Day's Range||0.0876 - 0.0876|
|52 Week Range||0.0838 - 0.2740|
|Beta (5Y Monthly)||1.65|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining...
IRVING, Texas, June 29, 2022--McKesson Corporation (NYSE: MCK) will release its first quarter fiscal 2023 financial results after market close on Wednesday, August 3, 2022. The company will host a live webcast of the earnings conference call for investors at 4:30 PM Eastern Time to review its financial results.
IRVING, Texas & NASHVILLE, Tenn., June 23, 2022--McKesson Corporation (NYSE: MCK) and HCA Healthcare, Inc. (NYSE: HCA) announced today an agreement to form a joint venture combining McKesson’s US Oncology Research (USOR) and HCA Healthcare’s Sarah Cannon Research Institute (SCRI). USOR is the research arm of McKesson’s The US Oncology Network and draws from a network of experienced investigators and dedicated clinical staff who specialize in oncology clinical trials. SCRI, which is the research